Advertisement
A surge in prescriptions for hydroxychloroquine/chloroquine was seen during the COVID-19 pandemic

Hydroxychloroquine Prescriptions Surge in U.S. During Pandemic

0
Increase in hydroxychloroquine/chloroquine fills seen during week of March 15 to 21, 2020
Body mass index is associated with tracheal intubation and/or death within seven days among individuals with diabetes hospitalized for COVID-19

BMI, Tracheal Intubation/Death Linked in Diabetes With COVID-19

0
In multivariable analyses with covariates, only BMI was positively linked to primary outcome
Despite adoption of enhanced safety measures

Radiation Oncology Clinic Visits Down Due to COVID-19

0
Patient volume decreased despite vast majority of practices adopting enhanced safety practices
A significant decline was seen in the monthly surgical case volume of acute type A aortic dissection in New York City after COVID-19

Significant Drop Seen in Type A Aortic Dissection After COVID-19

0
Monthly surgical case volume of aortic dissection declined 76.5 percent; volumes low in March, April
Health care workers in Italy who treated COVID-19 patients self-report substantial mental health symptoms

Italian Health Care Workers’ Mental Health Suffering During COVID-19

0
Symptoms of posttraumatic stress disorder, depression, anxiety, and insomnia all common
The first human trial of an antibody therapy to treat COVID-19 is underway

Human Trial of Antibody Therapy to Treat COVID-19 Underway

0
If drug proves safe and effective, it could be available for use by the fall
For patients with cancer and COVID-19

ASCO: Mortality High for Cancer Patients With COVID-19

0
Factors linked to 30-day mortality include age, male sex, smoking status, comorbidities, active cancer
For residents of California and Washington with COVID-19

Burden of Severe COVID-19 High in California, Washington State

0
Length of stay was 9.3 days for survivors; probability high for ICU admission, mortality
There seems to be no significant difference between a five- and 10-day course of remdesivir for patients with severe COVID-19 not requiring mechanical ventilation

Five-Day Course of Remdesivir Beneficial in Severe COVID-19

0
No significant difference seen in five-, 10-day course for severe COVID-19 without mechanical ventilation
For children and young adults receiving CD19 chimeric antigen receptor T-cell infusion

Infection Risk Up in Month After CAR T-Cell Immunotherapy

0
Infection rates increase in patients with ALL aged ≤26 years in first month, then decrease at days 29 to 90